The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
LARIMAR THERAPEUTICS INC COM 517125100   1,206,720 292,184 SH   SOLE   292,184 0 0
VIRIDIAN THERAPEUTICS INC COM 92790C104   6,119,641 209,505 SH   SOLE   209,505 0 0
F-STAR THERAPEUTICS INC COM 30315R107   3,633,975 574,996 SH   SOLE   574,996 0 0
SNAP INC CL A 83304A106   2,197,753 245,559 SH   SOLE   0 0 245,559
ROKU INC COM CL A 77543R102   2,348,675 57,707 SH   SOLE   57,707 0 0
DRAFTKINGS INC COM CL A 26142V105   74,668,375 6,555,608 SH   SOLE   6,555,608 0 0
INTEGRAL AD SCIENCE HLDNG CO COM 45828L108   199,733,157 22,722,771 SH   SOLE   22,722,771 0 0